Please login to the form below

Not currently logged in
Email:
Password:

BenevolentAI

This page shows the latest BenevolentAI news and features for those working in and with pharma, biotech and healthcare.

Recursion raises $121m for AI-led drug discovery

Recursion raises $121m for AI-led drug discovery

Numerous other companies are pioneering AI-led drug discovery, including Berg, BenevolentAI, Insilico Medicine and Exscientia.

Latest news

More from news
Approximately 5 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Has AI been the key to tackling the COVID-19 pandemic? Has AI been the key to tackling the COVID-19 pandemic?

    UK-based BenevolentAI is just one such company that has used AI and machine learning to aid drug discovery.

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Its potential to treat COVID-19 was discovered by UK firm BenevolentAI. ... For example, the aforementioned BenevolentAI has arrangements in place with Novartis and AstraZeneca (the latter also works with DeepMatter), while Boehringer Ingelheim has a

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    6. PROF. JOANNA HOLBROOK. Professor Joanna Holbrook is director, translational biology at BenevolentAI, pioneers of AI-based drug discovery and development. ... The firms will work together to combine. AZ’s genomics, chemistry and clinical data with

  • European venture funding for the life science sector European venture funding for the life science sector

    BenevolentAI, rumoured to enjoy a ‘unicorn’ valuation, has Woodford and Landsdowne as major investors.

  • AI’s potential in the pharma life cycle AI’s potential in the pharma life cycle

    Taking part in the discussion were Mark Davies, vice president of biomedical informatics at BenevolentAI; Jackie Hunter, CEO of the BenevolentBio division of BenevolentAI; Martin Gouldstone, partner at Results Healthcare; Steve

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • BenevolentAI appoints new head of cheminformatics BenevolentAI appoints new head of cheminformatics

    Dr Nathan Brown joins from the Institute of Cancer Research. Artificial Intelligence (AI) group BenevolentAI has appointed Dr Nathan Brown as its new head of cheminformatics. ... Jackie Hunter, CEO of BenevolentBio, the bioscience subsidiary of

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics